Prof. dr. Chris Meijer, MD Chief Executive Officer
Chris is co-founder, innovator and CEO of Self-screen B.V. and an emeritus professor in Pathology. Chris Meijer was Director of the Department of Pathology and of the Oncology Research Institute at the VU University Medical Center, Amsterdam Chris is a renowned key opinion leader in the HPV field. He holds a long track record in clinical cervical cancer research.. He is (co)author of over 1.000 international peer reviewed papers in his area of expertise and has received several international awards for his outstanding research. He has been a driving force in the introduction of primary HPV screening and the addition of self-sampling in The Netherlands as well as the development of International Guidelines for HPV screening assays in order to support qualitative, clinically well-developed tests. Within Self-screen he promotes the developments of continuous improvements towards full molecular screening.